Xbrane Biopharma AB Market Cap

Xbrane Biopharma AB has a market cap or net worth of 361.60 million as of July 8, 2025. Its market cap has decreased by -17.77% in one year.

Market Cap

361.60M

Enterprise Value

486.49M

Revenue

277.89M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.23

Market Cap Chart

Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 361.60M, an increase of 175.91%. That is a compound annual growth rate of 11.36%.

Market Cap History

Date	Market Cap	% Change
Jul 8, 2025	361.60M	47.03%
Dec 30, 2024	245.94M	-17.28%
Dec 29, 2023	297.31M	-86.83%
Dec 30, 2022	2.26B	-13.94%
Dec 30, 2021	2.62B	58.03%
Dec 30, 2020	1.66B	211.34%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Swedish Orphan Biovitrum AB	98.23B
Sectra AB	67.75B
Getinge AB	51.75B
Asker Healthcare Group AB	41.10B
Camurus AB	40.11B
Medicover AB	39.56B
AddLife AB	22.62B
Vimian Group AB	21.99B

Market Cap Rankings